Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-11
1998-06-09
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548235, C07D41306
Patent
active
057634670
ABSTRACT:
Certain 1-(benzyl or 5-benzofuranylmethyl)-1-hydroxyurea derivatives are useful as hypoglycemic and hypocholesterolemic agents.
REFERENCES:
patent: 3437664 (1969-04-01), Krenzer
patent: 3895023 (1975-07-01), Sharpe
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4342771 (1982-08-01), Schnur
patent: 4367234 (1983-01-01), Schnur
patent: 4406910 (1983-09-01), Pilgrim et al.
patent: 4617312 (1986-10-01), Schnur
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4725610 (1988-02-01), Meguro
patent: 4758263 (1988-07-01), Krenzer
patent: 4826990 (1989-05-01), Musser et al.
patent: 4895953 (1990-01-01), Musser et al.
patent: 5239080 (1993-08-01), Sohda et al.
patent: 5428048 (1995-06-01), Malamas et al.
patent: 5459154 (1995-10-01), Malamas et al.
patent: 5468760 (1995-11-01), Malamas et al.
patent: 5480896 (1996-01-01), Malamas
Sohda, et al., Chem. Pharm. Bull. Japan, 30, 3580-3600 (1982).
Goldstein Steven Wayne
McDermott Ruth Elsbree
Benson Gregg C.
Daus Donald G.
Jones James T.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Hypoglycemic hydroxyurea derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic hydroxyurea derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic hydroxyurea derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199552